Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 2 Radiation Injuries 1 Prostatic Neoplasms 1 Popliteal Cyst 1 Pneumonia 1 Optic Neuritis 1 Myelitis, Transverse 1 Myelitis 1 Myasthenia Gravis 1 Glioma 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

rozanolixizumab 7 zilucoplan 6 efgartigimod alfa 5 eculizumab 4 telitacicept 3 ravulizumab 3 Tacrolimus 3 Rituximab 3 Amifampridine 3 Prednisone 2 Mycophenolic Acid 2 HBM9161 2 satralizumab 1 remibrutinib 1 iptacopan 1 inebilizumab 1 Thymectomy 1 Sugars 1 Steroids 1 Sodium Chloride 1 Pyridostigmine Bromide 1 Prednisolone 1 Plasmapheresis 1 Leflunomide 1 Immunoglobulins, Intravenous 1 Hizentra 1 Cladribine 1 Azathioprine 1 Alkalies 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Myasthenia Gravis × Adrenal Cortex Hormones × Clear all

NCT06342544 2026-01-21

IMCOMG

Fondation Ophtalmologique Adolphe de Rothschild

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡